Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea.

Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder characterized by uncontrolled terminal complement activation. Eculizumab, a monoclonal antibody C5 inhibitor was introduced in Korea in 2009 and has been the standard treatment option for PNH.

Methods: This study assessed the long-term efficacy/safety of eculizumab in PNH using real-world data from the Korean Health Insurance Review and Assessment Service.

Graphene/polydimethylsiloxane nanocomposite strain sensor.

The objective of this research is to fabricate graphene nanopowder composites based on polydimethylsiloxane (PDMS) and to characterize the gauge factor of the graphene/PDMS composites for the use of strain sensors. The fabrication of graphene/PDMS composites can be accomplished by simple sonication and micro molding processes. We found that the measured gauge factors strongly depend on the concentration of graphene flakes in the composites.